Amanda Lantow, MSN, PMHNP-BC specializes in the administration of SPRAVATO® (esketamine), a FDA-approved nasal spray used alongside an oral antidepressant for adults with treatment-resistant depression (TRD) or major depressive disorder (MDD) with suicidal ideation. This innovative therapy has shown promising results in providing rapid relief to individuals who have not responded adequately to other treatments.
In addition, Amanda specializes in the evaluation and management of psychiatric medication for depression, anxiety, bipolar disorder, and other diagnoses and provides personalized treatment plans for patients. Amanda can also help link patients to adjunct treatments as needed, including transcranial magnetic stimulation (TMS), IV ketamine and/or talk therapy.
Relief Mental Health is a leading outpatient provider of transcranial magnetic stimulation (TMS), psychedelics (SPRAVATO® esketamine and IV ketamine), psychiatric medication management, and psychotherapy, for the treatment of depression, obsessive compulsive disorder, anxiety and other diagnoses. Founded in January 2020 and dedicated to delivering expedited care, Relief has 10 facilities in three states. In Illinois, clinics are located in Chicago (Lakeview and West Loop), Oak Brook, Orland Park, Northbrook, Rockford, and St. Charles. Relief’s other clinics are in Warren and Red Bank, New Jersey, and West Allis, Wisconsin. With a commitment to evidence-based care, Relief Mental Health continually explores innovative treatments to provide the best possible outcomes. For more information or to get started today, Amanda welcomes you to call!